Amphotericin B Formulated in Liposomes and Lipid Based Systems: A Review

References

• Lyman C. A., Walsh T. J. Systematically administered antifungal agents; a review of their clinical pharmacology and therapeutic applications. Drugs 1992; 44: 9
   PubMed Web of Science ®Google Scholar
• Bolard J. How do polyene macrolide antibiotics affect the cellular membrane properties?. Biochim. Biophys. Acta 1986; 864: 257
   PubMed Web of Science ®Google Scholar
• Witzke N., Bittman R. Dissociation kinetics and equilibrium binding properties of polyene antibiotic complexes with phosphatidylcholine/sterol vesicles. Biochemistry 1984; 23: 1668
   PubMed Web of Science ®Google Scholar
• New R. R. C., Chance M. L., Heath S. Antileishmanial activity of amphotericin B and other antifungal agents entrapped in liposomes. J. Antimicrobial Chemotherapy 1981; 8: 371
   PubMed Web of Science ®Google Scholar
• Taylor R. L., Williams D. M., Craven P. C., Graybill J. R., Drutz D. J., Magee W. E. Amphotericin B in liposomes: a novel therapy for histoplasmosis. Am. Rev. Resp. Dis. 1982; 125: 610
   PubMedGoogle Scholar
• Graybill J. R., Craven P. C., Taylor R. L., Williams D. M., Magee W. E. Treatment of murine cryptococcosis with liposome-associated amphotericin B. J. Infectious Dis. 1982; 145: 748
   PubMed Web of Science ®Google Scholar
• Lopez-Berestein G., Mehta R., Hopfer R. L., Mills K., Kasai L., Mehta K., Fainstein V., Luna M., Hersh E. M., Juliano R. Treatment and prophylaxis of disseminated infection due to Candida albicans in mice with liposomal-encapsulated amphotericin B. J. Infectious Dis. 1983; 147: 939
   PubMed Web of Science ®Google Scholar
• Tremblay C., Barza M., Fiore C., Szoka F. Efficacy of liposome-intercalated amphotericin B in the treatment of systemic Candidiasis in mice. Antimicrob. Agts. Chemother. 1984; 26: 170
   PubMed Web of Science ®Google Scholar
• Lopez-Berestein G., Fainstein V., Hopfer R., et al. Liposomal amphotericin B for the treatment of systemic fungal infections in patients with cancer: a preliminary study. J. Infectious Dis. 1985; 151: 704
   PubMed Web of Science ®Google Scholar
• Sculier J.-P., Coune A., Meunier F., et al. Pilot study of amphotericin b entrapped in sonicated liposomes in cancer patients with fungal infections. Eur. J. Clin. Oncol. 1988; 24: 527
   PubMedGoogle Scholar
• Szoka F. C., Jr., Milholland D., Barza M. Effect of lipid composition and liposome size on toxicity and in vitro fungicidal activity of liposome-intercalated amphotericin B. Antimicrob. Agts Chemother. 1987; 31: 421
   PubMed Web of Science ®Google Scholar
• Janoff A. S., Boni L. T., Popescu M. C., Minchey S. R., Cullis P. R., Madden T. D., Taraschi T., Gruner S. M., Shyamsunder E., Tate M. W., Mendelsohn R., Bonner D. Unusual lipid structures selectively reduce the toxicity of amphotericin B. Proc. Nad. Acad. Sci. U. S. A. 1988; 85: 6122
   PubMed Web of Science ®Google Scholar
• Patterson T. F., Miniter P., Dijkstra J., Szoka F. C., Ryan J. L., Andriole V. T. Treatment of experimental invasive Aspergillosis with novel amphotericin B/cholesterol sulfate complexes. J. Infectious Dis. 1989; 159: 717
   PubMed Web of Science ®Google Scholar
• Kirsh R., Goldstein R., Tarloff J., Parris D., Hook J., Hanna N., Bugelski, Poste G. An emulsion formulation of amphotericin B improves the therapeutic index when treating systemic murine Candidiasis. J. Infectious Dis. 1988; 158: 1065
   PubMed Web of Science ®Google Scholar
• Gruda I., Milette D., Brother M., Kobayashi G. S., Medoff G., Brajtburg J. Structure-activity study of inhibition of amphotericin B(Fungizone) binding to sterols, toxicity to cells and lethality to mice by esters of sucrose. Antimicrob. Agts. Chemother. 1991; 35: 24
   PubMed Web of Science ®Google Scholar
• Janoff A. S., Perkins W. R., Saletan S. L., Swenson C. E. Amphotericin B lipid complex (ABLC): a molecular rationale for the attentuation of amphotericin B related toxicities. J. Liposome Research 1993, in press
   Google Scholar
• Adler-Moore J. P., Proffitt R. T. Development, characterization, efficacy and mode of action of AmBisome, a unilamellar liposomal formulation of amphotericin B. J. Liposome Research 1993, in press
   Google Scholar
• Guo L. S. S., Working P. K. Complexes of amphotericin B and cholesteryl sulfate. J. Liposome Research 1993, in press
   Google Scholar
• Ellis E. G., Sobel R. A., Nielsen S. L. Leukoencephalopathy in patients treated with amphotericin B methyl ester. J. Infectious Dis. 1982; 146: 125
   PubMed Web of Science ®Google Scholar
• Coune A. Amphotericin B as a potentiating agent to cytotoxic chemotherapy. Eur. J. Clin. Oncol. 1988; 24: 117
   PubMedGoogle Scholar